Companion research to support your life-science innovation development efforts to save every patient.
Because we believe in “Patient Innovation First.
Infectious Disease | Ultra-Rare, Rare & Orphan Disease
Oncology Medicine | Real-World Evidence
Virtual Clinical Trials | Innovation Development
Digital Health Solutions | Advisory & Consulting
Disease & Cancer Genetics
Research and Development
Virtual trial Design / Real-World Evidence
Post Market Surveillance
Advisory & Consulting
Innovation Along the Patient Journey Continuum
Our mission is to ensure that therapeutics and vaccines developed within the life science industry factor in every patient ethnicity and demographics to bolster product efficacy, health equity, and effective patient outcomes.
At Rubix LS, we understand that practical therapeutic innovation doesn’t just happen within the lab; it occurs throughout the entire patient journey. Enabling better and diverse health outcomes starts by designing your early-stage development focus that encompasses various data sets.
Also supporting the federal missions.
We create the products that we’d like to see in the world today. We’re working with multiple organizations to create access and potential therapeutic opportunities to ensure that novel innovations can be accessed for everyone.
Latest News & Articles
Recently our Founder and CEO, Reginald Swift, sat down with the team at Pharma Tech Outlook magazine to discuss the changes happening with the pharma industry and how digital health, particularly virtual clinical trials are mobilizing access of pipeline therapeutics...
Rubix LS has joined the federal consortium of industry partners to fully develop plans and strategies for mobilizing robust response measures toward the growing COVID-19 worldwide pandemic in the United States. Rubix LS is joined by countless other firms, within the...